Hagens Berman Securities Lawyers

Sound investment decisions can only be made when you have full disclosure of accurate information. No money manager, retirement fund or individual investor should suffer undue risk and incur losses due to misrepresentations related to the investment at issue.

Our attorneys work for defrauded institutional and individual investors impacted by poor corporate governance, breach of fiduciary duties, or a failure of good faith, fair dealing or loyalty. The firm vigorously pursues fraud recovery litigation, forcing corporate officers, directors and fund managers to answer to their investors.

Below are cases in active investigation or cases with deadlines class members must meet in order to be considered a lead plaintiff. For further information on each, click on the links below and provide the requested information, or contact Reed Kathrein or Peter Borkon at 510-735-3000.

Current Cases

Valeant Pharmaceuticals International, Inc. NYSE: VRX
Fifth Street Finance Corp. NASDAQ: FSC
AAC Holdings, Inc. NYSE: AAC
Exchange-Traded Funds (NYSEArca: DVY), (NYSEArca: RSP), (NYSEArca: SPLV), (NYSEArca: HACK), (NYSEArca: IJR), (IVV), (NYSEArca: SCHA), (NYSEArca: VB), (NYSEArca: VDC) and (NYSEArca: VHT)
Plains All American Pipeline, L.P. NYSE: PAA, PAGP
Pimco Total Return Active ETF NYSEArca: BOND